Esperion Therapeutics, Inc. (0IIM.L)

USD 1.19

(-8.1%)

Inventory Summary of Esperion Therapeutics, Inc.

  • Esperion Therapeutics, Inc.'s latest annual inventory in 2023 was 65.62 Million USD , up 86.42% from previous year.
  • Esperion Therapeutics, Inc.'s latest quarterly inventory in 2024 Q1 was 73.09 Million USD , up 11.39% from previous quarter.
  • Esperion Therapeutics, Inc. reported annual inventory of 35.2 Million USD in 2022, up 2.35% from previous year.
  • Esperion Therapeutics, Inc. reported annual inventory of 34.39 Million USD in 2021, up 113.15% from previous year.
  • Esperion Therapeutics, Inc. reported quarterly inventory of 73.09 Million USD for 2024 Q1, up 11.39% from previous quarter.
  • Esperion Therapeutics, Inc. reported quarterly inventory of 51.43 Million USD for 2023 Q3, up 12.61% from previous quarter.

Annual Inventory Chart of Esperion Therapeutics, Inc. (2023 - 1999)

Historical Annual Inventory of Esperion Therapeutics, Inc. (2023 - 1999)

Year Inventory Inventory Growth
2023 65.62 Million USD 86.42%
2022 35.2 Million USD 2.35%
2021 34.39 Million USD 113.15%
2020 16.13 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2002 - USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%

Peer Inventory Comparison of Esperion Therapeutics, Inc.

Name Inventory Inventory Difference
uniQure N.V. 12.02 Million USD -445.767%
Agios Pharmaceuticals, Inc. 19.07 Million USD -244.008%
Amicus Therapeutics, Inc. 59.69 Million USD -9.929%
Atara Biotherapeutics, Inc. 9.7 Million USD -576.108%
bluebird bio, Inc. 22.91 Million USD -186.326%
Cara Therapeutics, Inc. 2.82 Million USD -2226.232%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 82.993%
Myriad Genetics, Inc. 20.1 Million USD -226.483%
Neurocrine Biosciences, Inc. 38.3 Million USD -71.339%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 15.225%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.211%
Waters Corporation 516.23 Million USD 87.288%
Thermo Fisher Scientific Inc. 5.08 Billion USD 98.71%
Biogen Inc. 2.52 Billion USD 97.404%
Nektar Therapeutics 16.1 Million USD -307.571%
Perrigo Company plc 1.14 Billion USD 94.248%
Dynavax Technologies Corporation 53.29 Million USD -23.143%
Illumina, Inc. 587 Million USD 88.821%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD -532.694%
Heron Therapeutics, Inc. 42.11 Million USD -55.837%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 94.073%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -496.681%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 97.457%
FibroGen, Inc. 41.56 Million USD -57.88%
Agilent Technologies, Inc. 1.03 Billion USD 93.635%
OPKO Health, Inc. 65.69 Million USD 0.113%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 26.387%
Exelixis, Inc. 17.32 Million USD -278.82%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 97.441%
Axsome Therapeutics, Inc. 15.13 Million USD -333.584%
Abeona Therapeutics Inc. -2.44 Million USD 2785.065%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 91.118%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD -130.864%
Sarepta Therapeutics, Inc. 322.85 Million USD 79.674%
Corcept Therapeutics Incorporated 7.73 Million USD -748.939%
Halozyme Therapeutics, Inc. 127.6 Million USD 48.572%
Blueprint Medicines Corporation 21.22 Million USD -209.207%
Insmed Incorporated 83.24 Million USD 21.172%
TG Therapeutics, Inc. 39.82 Million USD -64.787%
Incyte Corporation 62.97 Million USD -4.21%
Emergent BioSolutions Inc. 328.9 Million USD 80.048%